Pharmacology: A Patient-Centered Nursing Process Approach 12th Edition
by Linda E. McCuistion PhD MSN RN, Kathleen Vuljoin DiMaggio MSN RN (2025)
||LATEST EDITION||GRADED A+|| FULL TEST BANK
,Table of Contents
Unit 1: Introduction To Pharmacology .................................................................................................................................... 4
Chapter 01: The Nursing Process And Patient-Centered Care................................................................................................ 4
Chapter 02: Drug Development And Ethical Considerations .................................................................................................. 10
Chapter 03: Pharmacokinetics And Pharmacodynamics ........................................................................................................ 20
Chapter 04: Pharmacogenetics ............................................................................................................................................... 37
Chapter 05: Complementary And Alternative Therapies........................................................................................................ 41
Chapter 06: Pediatric Considerations ..................................................................................................................................... 47
Chapter 07: Geriatric Considerations ..................................................................................................................................... 59
Chapter 08: Drugs In Substance Use Disorder ........................................................................................................................ 64
Unit 2: Pharmacotherapy And Drug Administration ........................................................................................................... 73
Chapter 09: Safety And Quality .............................................................................................................................................. 73
Chapter 10: Drug Administration ............................................................................................................................................ 84
Chapter 11: Drug Calculations ................................................................................................................................................ 92
Unit 3: Maintenance Of Homeostasis ................................................................................................................................... 101
Chapter 12: Fluid Volume And Electrolytes ......................................................................................................................... 101
Chapter 13: Vitamin And Mineral Replacement ................................................................................................................... 115
Chapter 14: Nutritional Support ............................................................................................................................................ 121
Unit 4: Autonomic Nervous System Drugs .......................................................................................................................... 129
Chapter 15: Adrenergic Agonists And Antagonists ............................................................................................................... 129
Chapter 16: Cholinergic Agonists And Antagonists .............................................................................................................. 136
Unit 5: Central And Peripheral Nervous System Drugs..................................................................................................... 146
Chapter 18: Depressants ....................................................................................................................................................... 146
Chapter 19: Antiseizure Drugs ............................................................................................................................................. 152
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease .............................................................................................. 158
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ................................................................................ 165
Unit 6: Mental And Behavioral Health Drugs ..................................................................................................................... 171
Chapter 22: Antipsychotics And Anxiolytics ....................................................................................................................... 171
Chapter 23: Antidepressants And Mood Stabilizers .............................................................................................................. 179
Unit 7: Pain And Inflammation Management Drugs.......................................................................................................... 186
Chapter 24: Antiinflammatories........................................................................................................................................... 186
Chapter 25: Analgesics ......................................................................................................................................................... 192
Unit 8: Antimicrobial Drugs.................................................................................................................................................. 199
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins..................................................................................... 199
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides ............................ 205
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ....................................................... 209
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ............................................................................................... 212
Chapter 30: Antituberculars, Antifungals, And Antivirals................................................................................................... 216
Chapter 31: Antimalarials, An The Lmintics, And Peptides ............................................................................................... 225
Unit 9: Immunologic Drugs ................................................................................................................................................... 228
Chapter 32: HIV- And AIDS-Related Drugs......................................................................................................................... 228
, Chapter 33: Transplant Drugs ............................................................................................................................................... 232
Chapter 34: Vaccines............................................................................................................................................................ 234
Unit 10: Antineoplastics And Biologic Response Modifiers ............................................................................................... 238
Chapter 35: Anticancer Drugs ............................................................................................................................................... 238
Chapter 36: Targeted Therapies To Treat Cancer ................................................................................................................ 244
Chapter 37: Biologic Response Modifiers............................................................................................................................ 248
Unit 11: Respiratory Drugs ................................................................................................................................................... 254
Chapter 38: Upper Respiratory Disorders ............................................................................................................................. 254
Chapter 39: Lower Respiratory Disorders ............................................................................................................................. 261
Unit 12: Cardiovascular Drugs ............................................................................................................................................. 268
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics............................................................................... 269
Chapter 41: Diuretics ............................................................................................................................................................ 279
Chapter 42: Antihypertensives ............................................................................................................................................. 285
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics .......................................................................................... 293
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ............................................................. 303
Unit 13: Gastrointestinal Drugs ............................................................................................................................................ 310
Chapter 45: Gastrointestinal Tract Disorders ....................................................................................................................... 310
Chapter 46: Antiulcer Drugs ................................................................................................................................................. 319
Unit 14: Eye, Ear, And Skin Drugs....................................................................................................................................... 327
Chapter 47: Eye And Ear Disorders ...................................................................................................................................... 327
Chapter 48: Dermatologic Disorders ..................................................................................................................................... 333
Unit 15: Endocrine Drugs ...................................................................................................................................................... 339
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders .................................................................................... 339
Chapter 50: Antidiabetics ..................................................................................................................................................... 349
Unit 16: Renal And Urologic Drugs...................................................................................................................................... 358
Chapter 51: Urinary Disorders .............................................................................................................................................. 358
Unit 17: Reproductive And Gender-Related Drugs ............................................................................................................ 365
Chapter 52: Pregnancy And Preterm Labor .......................................................................................................................... 365
Chapter 53: Labor, Delivery, And Postpartum ...................................................................................................................... 375
Chapter 54: Neonatal And Newborn ..................................................................................................................................... 382
Chapter 55: Women’s Reproductive Health......................................................................................................................... 385
Chapter 56: Men’s Health And Reproductive Disorders ....................................................................................................... 395
Chapter 57: Sexually Transmitted Infections ........................................................................................................................ 402
Unit 18: Sexually Transmitted Infections ............................................................................................................................ 406
Chapter 58: Adult And Pediatric Emergency Drugs.............................................................................................................. 406
, Unit 1: Introduction To Pharmacology
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. All Of The Following Would Be Considered Subjective Data, EXCEPT:
a. Patient-Reported Health History
b. Patient-Reported Signs And Symptoms Of The Ir Illness
c. Financial Barriers Reported By The Patient’s Caregiver
d. Vital Signs Obtained From The Medical Record
ACCURATE ANS>>D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse. Patient-
Reported Health History, Signs And Symptoms, And Caregiver Reported Financial Barriers Would Be
Considered Subjective Data. Vital Signs Obtained From The Medical Record Would Be Considered
Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The
Most Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
a. Recognizing Cues (Assessment)
b. Analyze Cues & Prioritize Hypo The Sis (Analysis)
c. Generate Solutions (Planning)
d. Take Action (Nursing Interventions)
ACCURATE ANS>>C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The
Patient’s Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes.
Recognizing Cues (Assessment) Involves The Ga The Ring Of Cues (Information) From The Patient
About The Ir Health And Lifestyle Practices, Which Are Important Facts That Aid The Nurse In
Making Clinical Care Decisions. Prioritizing Hypo The Sis Is Used To Organize And Rank The Patient
Problem(S) Identified. Finally, Taking Action Involves Implementation Of Nursing Interventions To
Accomplish The Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management Of Client Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That The Y Can’t Keep Track Of
Everything That Has To Be Done To Care For The Ir Child. The Nurse Reviews Medications,
Diet, And Symptom Management With The Parents And Draws Up A Daily Checklist For
The Family To Use. The Se Activities Are Completed In Which Step Of The Nursing
Process?
a. Recognizing Cues (Assessment)
by Linda E. McCuistion PhD MSN RN, Kathleen Vuljoin DiMaggio MSN RN (2025)
||LATEST EDITION||GRADED A+|| FULL TEST BANK
,Table of Contents
Unit 1: Introduction To Pharmacology .................................................................................................................................... 4
Chapter 01: The Nursing Process And Patient-Centered Care................................................................................................ 4
Chapter 02: Drug Development And Ethical Considerations .................................................................................................. 10
Chapter 03: Pharmacokinetics And Pharmacodynamics ........................................................................................................ 20
Chapter 04: Pharmacogenetics ............................................................................................................................................... 37
Chapter 05: Complementary And Alternative Therapies........................................................................................................ 41
Chapter 06: Pediatric Considerations ..................................................................................................................................... 47
Chapter 07: Geriatric Considerations ..................................................................................................................................... 59
Chapter 08: Drugs In Substance Use Disorder ........................................................................................................................ 64
Unit 2: Pharmacotherapy And Drug Administration ........................................................................................................... 73
Chapter 09: Safety And Quality .............................................................................................................................................. 73
Chapter 10: Drug Administration ............................................................................................................................................ 84
Chapter 11: Drug Calculations ................................................................................................................................................ 92
Unit 3: Maintenance Of Homeostasis ................................................................................................................................... 101
Chapter 12: Fluid Volume And Electrolytes ......................................................................................................................... 101
Chapter 13: Vitamin And Mineral Replacement ................................................................................................................... 115
Chapter 14: Nutritional Support ............................................................................................................................................ 121
Unit 4: Autonomic Nervous System Drugs .......................................................................................................................... 129
Chapter 15: Adrenergic Agonists And Antagonists ............................................................................................................... 129
Chapter 16: Cholinergic Agonists And Antagonists .............................................................................................................. 136
Unit 5: Central And Peripheral Nervous System Drugs..................................................................................................... 146
Chapter 18: Depressants ....................................................................................................................................................... 146
Chapter 19: Antiseizure Drugs ............................................................................................................................................. 152
Chapter 20: Drugs For Parkinsonism And Alzheimer Disease .............................................................................................. 158
Chapter 21: Drugs For Neuromuscular Disorders And Muscle Spasms ................................................................................ 165
Unit 6: Mental And Behavioral Health Drugs ..................................................................................................................... 171
Chapter 22: Antipsychotics And Anxiolytics ....................................................................................................................... 171
Chapter 23: Antidepressants And Mood Stabilizers .............................................................................................................. 179
Unit 7: Pain And Inflammation Management Drugs.......................................................................................................... 186
Chapter 24: Antiinflammatories........................................................................................................................................... 186
Chapter 25: Analgesics ......................................................................................................................................................... 192
Unit 8: Antimicrobial Drugs.................................................................................................................................................. 199
Chapter 26: Penicillins, Other Beta-Lactams, And Cephalosporins..................................................................................... 199
Chapter 27: Macrolides, Oxazolidinones, Lincosamides, Glycopeptides, Ketolides, And Lipopeptides ............................ 205
Chapter 28: Tetracyclines, Glycylcyclines, Aminoglycosides, And Fluoroquinolones ....................................................... 209
Chapter 29: Sulfonamides And Nitroimidazoles Antibiotics ............................................................................................... 212
Chapter 30: Antituberculars, Antifungals, And Antivirals................................................................................................... 216
Chapter 31: Antimalarials, An The Lmintics, And Peptides ............................................................................................... 225
Unit 9: Immunologic Drugs ................................................................................................................................................... 228
Chapter 32: HIV- And AIDS-Related Drugs......................................................................................................................... 228
, Chapter 33: Transplant Drugs ............................................................................................................................................... 232
Chapter 34: Vaccines............................................................................................................................................................ 234
Unit 10: Antineoplastics And Biologic Response Modifiers ............................................................................................... 238
Chapter 35: Anticancer Drugs ............................................................................................................................................... 238
Chapter 36: Targeted Therapies To Treat Cancer ................................................................................................................ 244
Chapter 37: Biologic Response Modifiers............................................................................................................................ 248
Unit 11: Respiratory Drugs ................................................................................................................................................... 254
Chapter 38: Upper Respiratory Disorders ............................................................................................................................. 254
Chapter 39: Lower Respiratory Disorders ............................................................................................................................. 261
Unit 12: Cardiovascular Drugs ............................................................................................................................................. 268
Chapter 40: Cardiac Glycosides, Antianginals, And Antidysrhythmics............................................................................... 269
Chapter 41: Diuretics ............................................................................................................................................................ 279
Chapter 42: Antihypertensives ............................................................................................................................................. 285
Chapter 43: Anticoagulants, Antiplatelets, And Thrombolytics .......................................................................................... 293
Chapter 44: Antihyperlipidemics And Drugs To Improve Peripheral Blood Flow ............................................................. 303
Unit 13: Gastrointestinal Drugs ............................................................................................................................................ 310
Chapter 45: Gastrointestinal Tract Disorders ....................................................................................................................... 310
Chapter 46: Antiulcer Drugs ................................................................................................................................................. 319
Unit 14: Eye, Ear, And Skin Drugs....................................................................................................................................... 327
Chapter 47: Eye And Ear Disorders ...................................................................................................................................... 327
Chapter 48: Dermatologic Disorders ..................................................................................................................................... 333
Unit 15: Endocrine Drugs ...................................................................................................................................................... 339
Chapter 49: Pituitary, Thyroid, Parathyroid, And Adrenal Disorders .................................................................................... 339
Chapter 50: Antidiabetics ..................................................................................................................................................... 349
Unit 16: Renal And Urologic Drugs...................................................................................................................................... 358
Chapter 51: Urinary Disorders .............................................................................................................................................. 358
Unit 17: Reproductive And Gender-Related Drugs ............................................................................................................ 365
Chapter 52: Pregnancy And Preterm Labor .......................................................................................................................... 365
Chapter 53: Labor, Delivery, And Postpartum ...................................................................................................................... 375
Chapter 54: Neonatal And Newborn ..................................................................................................................................... 382
Chapter 55: Women’s Reproductive Health......................................................................................................................... 385
Chapter 56: Men’s Health And Reproductive Disorders ....................................................................................................... 395
Chapter 57: Sexually Transmitted Infections ........................................................................................................................ 402
Unit 18: Sexually Transmitted Infections ............................................................................................................................ 406
Chapter 58: Adult And Pediatric Emergency Drugs.............................................................................................................. 406
, Unit 1: Introduction To Pharmacology
Chapter 01: The Nursing Process And Patient-Centered Care
Mccuistion: Pharmacology: A Patient-Centered Nursing Process Approach, 11th Edition
MULTIPLE CHOICE
1. All Of The Following Would Be Considered Subjective Data, EXCEPT:
a. Patient-Reported Health History
b. Patient-Reported Signs And Symptoms Of The Ir Illness
c. Financial Barriers Reported By The Patient’s Caregiver
d. Vital Signs Obtained From The Medical Record
ACCURATE ANS>>D
Subjective Data Is Based On What Patients Or Family Members Communicate To The Nurse. Patient-
Reported Health History, Signs And Symptoms, And Caregiver Reported Financial Barriers Would Be
Considered Subjective Data. Vital Signs Obtained From The Medical Record Would Be Considered
Objective Data.
DIF: Cognitive Level: Understanding (Comprehension) TOP: Nursing Process: Planning
MSC: NCLEX: Management Of Client Care
2. The Nurse Is Using Data Collected To Define A Set Of Interventions To Achieve The
Most Desirable Outcomes. Which Of The Following Steps Is The Nurse Applying?
a. Recognizing Cues (Assessment)
b. Analyze Cues & Prioritize Hypo The Sis (Analysis)
c. Generate Solutions (Planning)
d. Take Action (Nursing Interventions)
ACCURATE ANS>>C
When Generating Solutions (Planning), The Nurse Identifies Expected Outcomes And Uses The
Patient’s Problem(S) To Define A Set Of Interventions To Achieve The Most Desirable Outcomes.
Recognizing Cues (Assessment) Involves The Ga The Ring Of Cues (Information) From The Patient
About The Ir Health And Lifestyle Practices, Which Are Important Facts That Aid The Nurse In
Making Clinical Care Decisions. Prioritizing Hypo The Sis Is Used To Organize And Rank The Patient
Problem(S) Identified. Finally, Taking Action Involves Implementation Of Nursing Interventions To
Accomplish The Expected Outcomes.
DIF: Cognitive Level: Understanding (Comprehension)
TOP: Nursing Process: Nursing Intervention
MSC: NCLEX: Management Of Client Care
3. A 5-Year-Old Child With Type 1 Diabetes Mellitus Has Had Repeated Hospitalizations For
Episodes Of Hyperglycemia. The Parents Tell The Nurse That The Y Can’t Keep Track Of
Everything That Has To Be Done To Care For The Ir Child. The Nurse Reviews Medications,
Diet, And Symptom Management With The Parents And Draws Up A Daily Checklist For
The Family To Use. The Se Activities Are Completed In Which Step Of The Nursing
Process?
a. Recognizing Cues (Assessment)
